Showing results (101-110 of 424) with videos related to
Sort By:
Pageof 43
Abdominal Radiology (New York)|January 2, 2021
Current update on gallbladder carcinomaDhakshinamoorthy Ganeshan, Avinash Kambadakone, Paul Nikolaidis, et al.BMC Dermatology|April 18, 2015
Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case reportJennifer Goldstein, Anisha B Patel, Jonathan L Curry, et al.Cancer Treatment and Research Communications|September 30, 2025
Development of anti-cancer medicines in the current eraBradley J Monk, Manish R Patel, Sarper Toker, et al.Trends in Cancer|August 15, 2021
Precision therapy for RET-altered cancers with RET inhibitorsKyaw Z Thein, Vamsidhar Velcheti, Blaine H M Mooers, et al.BMC Medicine|September 15, 2021
The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapySreeram Ramagopalan, Thomas P Leahy, Joshua Ray, et al.Journal of the National Cancer Institute|November 9, 2017
Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma TumorsShiraj Sen, Funda Meric-Bernstam, David S Hong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 PatientsShumei Kato, Vivek Subbiah, Erica Marchlik, et al.NPJ Precision Oncology|June 8, 2021
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinibTao Shen, Xueqing Hu, Xuan Liu, et al.Current Treatment Options in Oncology|June 18, 2009
Ewing's sarcoma: standard and experimental treatment optionsVivek Subbiah, Pete Anderson, Alexander J Lazar, et al.Experimental Hematology|June 14, 2008
Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopeniaVivek Subbiah, Aaron D Viny, Steven Rosenblatt, et al.Pageof 43